USD10
TRVI Shares
About Trevi TherapeuticsTrevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

USD10
TRVI Shares
About Trevi TherapeuticsTrevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$2.26B

OPEN PRICE

$17.36

LOW (1Y)

$3.77

HIGH (1Y)

$14.39

LOW (24H)

$16.92

HIGH (24H)

$17.54

VOLUME (24H)

$1.65M

30.44%

Price history

Time
Price
Change
Today
$17.36
1.56%
1 Day
$17.54
0.54%
1 Week
$19.11
7.74%
1 Month
$17.90
1.51%
1 Year
$7.64
130.76%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.